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ABSTRACT
Apurinic/apyrimidinic endonuclease 1 (APE1), an
essential protein in mammals, is involved in base
excision DNA repair (BER) and in regulation of
gene expression, acting as a redox co-activator of
several transcription factors. Recent findings high-
light a novel role for APE1 in RNA metabolism, which
is modulated by nucleophosmin (NPM1). The results
reported in this article show that five lysine residues
(K24, K25, K27, K31 and K32), located in the APE1
N-terminal unstructured domain, are involved in the
interaction of APE1 with both RNA and NPM1, thus
supporting a competitive binding mechanism. Data
from kinetic experiments demonstrate that the APE1
N-terminal domain also serves as a device for fine
regulation of protein catalytic activity on abasic
DNA. Interestingly, some of these critical lysine
residues undergo acetylation in vivo. These results
suggest that protein–protein interactions and/or
post-translational modifications involving APE1
N-terminal domain may play important in vivo
roles, in better coordinating and fine-tuning protein
BER activity and function on RNA metabolism.
INTRODUCTION
APE1/Ref-1 (APE1) is an essential protein acting as a
master regulator of cellular responses to oxidative stress
and contributing to the maintenance of genome stability
(1–3). APE1 is involved both in the base excision repair
(BER) of DNA lesions, functioning as the major DNA
AP-endonuclease in mammals, and in transcription,
acting as a redox co-activator of different transcription
factors such as Egr-1, NF-kB and p53 (4,5). These bio-
logical activities are located in two functionally distinct
protein regions. The N-terminal domain (residues
1–127), containing the nuclear localization signal (NLS),
is mainly devoted to the transcriptional co-activating
function, while the C-terminal portion (residues 61–318)
exerts the enzymatic activity on abasic sites in DNA (4–7).
A third function, regulated by K6/K7 acetylation (8), is its
transcriptional repressor activity through indirect binding
to the negative Ca
2+-response elements (nCaRE) (9,10). A
completely unexpected new function has been recently
unveiled and is associated to a role in RNA metabolism
(11–13), which could explain some of the effects of
APE1 on gene expression through post-transcriptional
mechanisms.
Extensive structural investigations have shown that the
ﬁrst 42 amino acids of APE1 are disordered, while the
remainder of the protein has a globular fold (14–16).
APE1 homology with Escherichia coli ExoIII starts from
residue 62; a Blast homology search against non-
redundant databases clearly shows that the protein
C-terminus is highly conserved, while the N-terminus
(ﬁrst  40 residues) is not. Conservation of APE1
N-terminal portion is high in mammals (>90%) but
almost absent in other organisms, with the exception of
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sequence identity <40%), suggesting that it may be a
recent acquisition during evolution (17). Interestingly, the
Drosophila homologue of mammalian APE1 (i.e. Rrp1),
which also bears a bipartite arrangement, presents an un-
structuredN-terminaldomainwhichisusedtointeractwith
Pol z (18,19). Accordingly, data on the human APE1
(hAPE1) clearly show that protein N-terminus (ﬁrst  35
amino acids) is used for interacting with other partners,
such as XRCC1 (20), CSB (21), NPM1 and others (11),
possibly modulating the different APE1 functions. These
data underscore a common emerging theme in this
protein: the presence of an unstructured N-terminus for
mediating protein–protein interaction. Its truncation has
been related to an enhanced immune cell death mediated
by granzyme A and K (22,23), to a reduction of hAPE1
accumulation within nuclei (22,24) and to a loss of its inter-
action with XRCC1 (20) and other protein partners (11).
A truncated form has also been detected in mitochondria,
where itcould exert arole in mtDNA repair (25–27). Asthe
proteinlackingtheﬁrst33residues(hAPE1N33)hasbeen
associated with an apoptotic phenotype (23), it cannot be
excluded that its generation may promote a cytotoxic
outcome, driving pro-apoptotic triggering directly within
mitochondria.
hAPE1 is mainly a nuclear protein and is critical for
controlling cellular proliferative rates (1,2,28). However,
cytoplasmic, mitochondrial and ER localizations have
also been reported (25–27,29,30). hAPE1 is an abundant
and relatively stable protein in mammalian cells (4,5).
Fine-tuning of the multiple hAPE1 functions may there-
fore depend on post-translational modiﬁcations (PTMs)
and on its interactome modulation. While a functional
role has been determined for some PTMs (K6/K7 acetyl-
ation and K24/K25/K27 ubiquitination) (8,31,32), the
identity and the role of the interacting partners in
modulating hAPE1 biological functions are still under in-
vestigation (11,31,33). By a proteomic approach, we
recently discovered that hAPE1, through its
33N-terminal amino acids (33N-term), may functionally
interact with different proteins involved in RNA metabol-
ism, unveiling its unexpected function in RNA cleansing
processes (11,12). We demonstrated that hAPE1 may
affect cell growth by directly acting on RNA
quality-control mechanisms, thus regulating gene expres-
sion through post-transcriptional mechanisms; in particu-
lar, hAPE1 interaction with NPM1 may affect its activity
over rRNA molecules. However, many aspects of this new
function are still unknown (12).
In this study, we explore the role of hAPE1 N-terminal
domain by analysing the molecular details of its binding to
both RNA and NPM1 and their impact on the DNA
repair activity of the protein. Five lysine residues,
located in the unstructured hAPE1 N-terminal domain
made of 33 amino acids (33N-term) probably acquired
during evolution, resulted crucial for hAPE1 interaction
with RNA and NPM1. Interestingly, we found that some
of these lysine residues resulted acetylated in vivo.
Moreover, kinetic/functional studies showed that the un-
structured 33N-term serves as a device for subtle regula-
tion of hAPE1 catalytic activity on abasic DNA through
regulation of product binding. These ﬁndings suggest that
other proteins can modulate hAPE1 BER activity and
ensure the correct processing of DNA intermediates and
may have an impact on the RNA cleansing process. These
data shed new light on the ﬁne-tuning mechanisms respon-
sible for hAPE1 regulation and open the way for develop-
ing new strategies for therapeutical intervention based on
the modulation of hAPE1 functions.
MATERIALS AND METHODS
Biophysical and evolutionary analysis of APE1 sequences
Biophysical parameters of different APE1 peptides
(molecular weight and pI) were calculated by the
computing algorithms available at the Swiss Institute of
Bioinformatics (http://www.expasy.ch/tools/pi_tool.html).
For phylogenetic analysis, a total of 17 APE1
orthologous metazoan sequences (Homo sapiens, Pan
troglodytes, Macaca mulatta, Equus caballus, Sus scrofa,
Bos taurus, Canis lupus familiaris, Mus musculus, Rattus
norvegicus, Ornithorhyncus anatinus, Xenopus laevis,
Xenopus tropicalis, Salmo salar, Danio rerio, Gasterosteus
aculeatus, Caenorhabditis elegans and Strongylocentrotus
purpuratus) were retrieved from databases using the
BLAST algorithm (34). Out-group sequences were not
included because of the almost complete lack of the
N-terminal domain in other organisms. Alignment of
the amino acid residues 1–60 and of the cDNA nucleotide
1–180 was made with the MAFFT program (v6.531b) (35)
with default parameters, and evolutionary trees were
inferred using the software MEGA version 4 (36). The
minimum evolution tree-building method was used to re-
construct the phylogenetic tree (37); dendrograms’
topologies were checked by the bootstrap method with
1000 replicates.
Cell culture and transient transfection experiments
HeLa cells were grown in Dulbecco’s modiﬁed Eagle’s
medium (DMEM) supplemented with 10% foetal calf
serum (FCS), 100U/ml penicillin and 10mg/ml strepto-
mycin sulphate. One day before transfection, cells were
seeded in 10cm plates at a density of 1.8 10
6cells/plate.
Cells were then transiently transfected with 2mg of either
pFLAG5.1 (empty vector) or pFLAG5.1-hAPE1 (wild-
type and speciﬁc mutant forms) plasmids per dish, using
Lipofectamine 2000 Reagent (Invitrogen, Milan, Italy)
according to the manufacturer’s instructions. Cells were
harvested 48h after transfection. Co-immunoprecipitation
analysis was performed as described earlier (11).
Western blot analysis
The protein samples were electrophoresed onto a 10–12%
sodium dodecyl sulphate-polyacrylamide gel electrophor-
esis (SDS–PAGE). Proteins were then transferred to nitro-
cellulose membranes (Schleicher & Schuell, Keene,
NH, USA), revealed as already described (11) using
ECL chemiluminescence procedure (GE Healthcare,
Milan, Italy) and quantiﬁed by using a Gel Doc 2000
video-densitometer (Bio-Rad, Milan, Italy).
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The constructs pGex3X-hAPE1 and pGex-3X-zAPE1,
coding for the glutathione S-transferase (GST)-hAPE1
and zebraﬁsh zAPE1 full-length proteins, respectively,
were kindly provided by Mark R. Kelley (Indiana
University, IN, USA). The constructs pGex3X-
N33hAPE1, pGex3X-22hAPE1 and pGex3X-
9hAPE1, coding for truncated hAPE1 forms were
generated by subcloning from the previous one through
PCR and conﬁrmed by direct sequencing. Plasmids
pGex3X-hAPE1K3 mutant (K24A, K25A, K27A) and
pGex3X-hAPE1K5 mutant (K24A, K25A, K27A,
K31A, K32A) were generated using the Quickchange II
XL Mutagenesis kit (Stratagene, Cedar Creek, TX, USA)
and the pGex3X-hAPE1 as template, following manufac-
turer’s instructions. The plasmid coding for GST-NPM1
full-length was kindly provided by P. G. Pelicci (European
Institute of Oncology, Milan, Italy). For expression of
His6-tagged NPM1, cDNA coding for full-length NPM1
was subcloned in the pET-15b-expressing plasmid
(Invitrogen).
All proteins were expressed in E. coli BL21(DE3),
induced with 1mM isopropyl-b-D-thiogalactopyranoside
(IPTG), and then puriﬁed on an AKTA Prime FPLC
system (GE Healthcare) by using a GSTrap HP column
(GE Healthcare) (for GST-tagged proteins) or a HisTrap
HP column (GE Healthcare) (for His6-NPM1). The
quality of puriﬁcation was checked by silver-stained
SDS–PAGE analysis. Extensive dialysis against PBS was
performed to remove any trace of imidazole from the
HisTrap-puriﬁed proteins.
Accurate quantiﬁcation of all recombinant proteins was
performed by colorimetric Bradford assays (Bio-Rad) and
conﬁrmed by SDS–PAGE and western blotting analysis
using anti-GST peroxidase-conjugated antibody (Sigma,
Milan, Italy). To remove the GST tag, GST–hAPE1 and
GST–hAPE1 mutant proteins were further hydrolyzed
with factor Xa (ﬁve factor Xa units per milligram of re-
combinant GST-fused protein). The protease was
removed from the sample using a benzamidine HiTrap
FF column (GE Healthcare); the proteins were then
puriﬁed on a GSTrap HP column (GE Healthcare).
The correct molecular mass of each recombinant
protein was assessed by LC–MS analysis.
Peptide synthesis
Reagents for peptide synthesis were from Novabiochem
(Laufelﬁngen, Switzerland) and Inbios (Pozzuoli, Italy).
Solid phase peptide syntheses were performed on an auto-
mated synthesizer Syro I (MultiSynTech, Witten,
Germany). Preparative RP–HPLC were carried out on a
Shimadzu LC-8A, using a Phenomenex Luna-COMBI
HTS C18 column (5 2.12cm, 10mm). LC–ESI–Ion
Trap (IT)-MS analysis was carried out on a Surveyor
HPLC system connected to a LCQ DECA XP IT
(Thermo Scientiﬁc, USA), hAPE1 peptide 1–33 was
purchased from EzBiolab (Westﬁeld, IN, USA) and used
without any further puriﬁcation. Peptides corresponding
to hAPE1 fragments 1–9 (in a free and acetylated version
in K6 and K7) and 23–33 were prepared following
standard Fmoc (9-ﬂuorenylmethoxycarbonyl) chemistry
protocols (38,39). Products were puriﬁed to homogeneity
by RP–HPLC and their identity and purity were con-
ﬁrmed by LC–MS analysis.
GST pull-down assay with RNA or NPM1 and co-
immunoprecipitation with NPM1 in transfected cells
An amount of 0.12nmol of either GST–hAPE1 or each
GST–hAPE1 mutant protein were added, together with
0.2nmol of NPM1 protein or 10mg of total RNA, to
10ml of glutathione–Sepharose 4B beads (GE
Healthcare). RNA was extracted using Trizol Reagent
(Invitrogen). Binding was performed in PBS supplemented
with 5mM DTT and 1 protease inhibitor cocktail
(Sigma) for 2h, under rotation, at 4 C. The beads were
washed three times with washing buffer (PBS) supple-
mented with 0.1% w/v Igepal CA-630 (Sigma), 5mM
DTT, 1 protease inhibitor cocktail. Beads were then re-
suspended in 1 Laemmli sample buffer containing
100mM DTT for western blot analysis or in Trizol
reagent for RNA extraction and rRNA quantiﬁcation.
For western blot experiments, GST-tagged and NPM1
proteins were detected with an anti-GST peroxidase-
conjugated antibody (Sigma) and an anti-NPM1 mono-
clonal antibody (NPM1: clone FC-61991; Invitrogen),
respectively.
Co-immunoprecipitation analyses of hAPE1 and its dif-
ferent mutants with NPM1 were performed as described
earlier (11).
Q-PCR analysis
Levels of 28S and 18S rRNA transcripts were determined
as described earlier (11) by using the iScript cDNA syn-
thesis kit (Bio-Rad) according to the manufacturer’s in-
structions. Q-PCR was performed with an iQ5 multicolor
real-time PCR detection system (Bio-Rad), according to
the manufacturer’s protocol. The following primers were
used: 18S_for (50-CTGCCCTATCAACTTTCGATGGT
AG-30) and 18S_rev (50-CCGTTTCTCAGGCTCCCT
CTC-30), which ampliﬁed a region of 100bp; 28S_for
(50-TGTCGGCTCTTCCTATCATTGT-30) and 28S_rev
(50-ACCCAGCTCACGTTCCCTATTA-30), which
ampliﬁed a region of 81bp.
Each sample analysis was performed in triplicate. As
negative control, a sample without the template was
used; as control for genomic DNA contamination, a
sample with non-retro-transcribed RNA was included
instead of template cDNA. The cycling parameters were
denaturation at 95 C for 10s and annealing/extension at
60 C for 30s (repeated 40 times). In order to verify the
speciﬁcity of the ampliﬁcation, a melting-curve analysis
was performed, immediately after the ampliﬁcation
protocol. A standard curve was generated by using a
calibrating cDNA. This cDNA was obtained from a
retrotranscription of 1mg of total RNA from HeLa cells,
which was serially diluted and analysed for 18S and 28S
rRNA. We assumed that rRNA represented 90% of the
total RNA, in a 28S/18S rRNA molar ratio of 2:1. By
using the equation describing the plots of the log10 of
the starting amount of ﬁve dilutions of the calibrator
Nucleic Acids Research, 2010,Vol.38, No. 22 8241cDNA versus the corresponding threshold cycle, the iQ5
optical system software calculated the amount of the
template for each sample.
Immunoﬂuorescence confocal analysis
For experiments on hAPE1-Flag/NPM1 colocalization, a
double immunoﬂuorescence procedure was carried out as
described earlier (11), where hAPE1 was labelled by an
anti-Flag antibody-FITC conjugate (Sigma), whereas
NPM1 was labelled with the Zenon Mouse IgG
Labeling Kit (Invitrogen), using the Alexa Fluor
546-labelled Fab fragment directed against the Fc
portion of the IgG primary anti-NPM1 antibody
(Invitrogen), according to the manufacturer’s instructions.
Nuclei were counterstained with DAPI (Sigma); micro-
scope slides were mounted and visualized through a
Leica TCS SP laser-scanning confocal microscope.
AP site incision assays on abasic dsDNA
Cleavage assays were performed as described earlier
(11,20) with some minor modiﬁcations and using a ﬂuor-
escent abasic dsDNA probe called 34FDNA (11). When
the effect of other proteins on the hAPE1 activity was
investigated, proteins were ﬁrst incubated in 5mM Tris–
HCl, pH 7.6, 5mM KCl, 1mM MgCl2, 0.1mg/ml bovine
serum albumin and 0.005% Triton X-100, on ice, for
20min. Then, 150fmol of the labelled duplex containing
a THF residue were added to each sample (11). Reactions
were carried out at 37 C, for 30min, and stopped
by adding 4ml of formamide dye (10mM EDTA,
0.5% Bromophenol Blue, 80% formamide) followed by
heating for 5min, at 95 C, before loading. Reaction
products were separated by denaturing 20% PAGE
(19:1 acrylamide:bis-acrylamide). Gels were scanned and
band intensities were quantiﬁed using a Storm
Phosphoimager (Molecular Dynamics).
hAPE1–RNA-binding assays through EMSA
hAPE1–RNA complex formation was assessed as
described earlier with a 34-mer synthetic RNA oligo-
nucleotide containing an abasic site called 34FRNA
(11), incubated on ice for 10min and separated onto a
native 8% w/v polyacrylamide gel at 120V, for 2h.
Each reaction contained 2.5pmol of 34FRNA labelled
substrate and the indicated amount of proteins in a ﬁnal
volume of 10ml.
Surface plasmon resonance experiments
Real time binding assays were performed on a Biacore
3000 Surface Plasmon Resonance (SPR) instrument
(GE Healthcare). Full-length hAPE1 and hAPE1N33
were immobilized on a CM5 Biacore sensor chip in
10mM sodium acetate, pH 5.5, by using the EDC/NHS
chemistry, with a reaction ﬂow rate of 5ml/min and a time
injection of 7min (40). Binding assays were carried out by
injecting 90ml of analyte, at 20ml/min, with HBS (10mM
HEPES, 150mM NaCl, 3mM EDTA, pH 7.4), 0.1mM
TCEP as running-buffer. BIAevaluation analysis package
(version 4.1, GE Healthcare), was used to subtract the
signal of the reference channel, while RUmax data versus
proteins concentrations were ﬁtted with GraphPad Prism,
vers. 4.00 (San Diego, CA), following a procedure
reported earlier (41).
Mass spectrometry analysis
Identiﬁcation of PTMs occurring on hAPE1 was per-
formed on immunopuriﬁed hAPE1 obtained from
hAPE1-Flag expressing HeLa cells (11). hAPE1 was
resolved by 12% SDS–PAGE; corresponding protein
band was excised, in-gel S-alkylated, digested with
endoprotease AspN and analysed as reported earlier
(11,42). Details on mass spectrometry analysis are
described in the Supplementary Data.
Statistical analysis
Statistical analysis was performed using the Microsoft
Excel data analysis program for Student’s t-test analysis.
P<0.05 was considered as statistically signiﬁcant.
RESULTS
Primary structure analysis of hAPE1N-terminal sequence
NPM1 and RNA interact with hAPE1 through its
33N-term (11). In order to map the speciﬁc residues re-
sponsible for binding, we performed a preliminary
analysis of the 33N-term sequence. Based on the distribu-
tion of charged amino acids at physiological pH, the
33N-term can be subdivided into three distinct regions:
(i) a ﬁrst basic sequence comprising amino acids 1–9,
(ii) an acidic sequence comprising the amino acids 10–22
and (iii) a second basic region, spanning amino acids
23–33 and containing ﬁve lysine residues (Figure 1A).
Interestingly, the 33N-term confers a calculated basic pI
(8.3) to the full-length protein, while its removal decreases
the pI to 6.6. These calculations were supported by experi-
mental evaluation of the pI of the two protein forms
through 2-DE analysis (Supplementary Figure S1).
The 33N-term peptide is able to bind RNA molecules
by itself
Previous in vitro experiments demonstrated that hAPE1 is
able to bind RNA (11). In this work, we veriﬁed that this
process reasonably occurs also in vivo, as demonstrated by
co-localization analysis of hAPE1 with RNA in HeLa cells
(Supplementary Figure S2). Due to its basic features, the
33N-term peptide could potentially bind to RNA by itself.
We therefore tested peptide binding to RNA by EMSA, as
described earlier (11). Figure 1B (left) shows that the
peptide 1–33 binds a 34-mer RNA oligonucleotide con-
taining an abasic sites (34FRNA) (11) and competes for
its binding with the full-length hAPE1 protein. More
striking results were obtained with rRNA, through GST
pull-down competition experiments (Figure 1B, right) and
with t-RNA molecules of different origins (data not
shown).
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We mapped the amino acids responsible for RNA bind-
ing through deletion analyses and competition assays
with peptides spanning the regions 1–9, 23–33 and 1–33.
The binding abilities of hAPE1N9, hAPE1N22
and hAPE1N33 (Figure 2A) were evaluated through
GST pull-down experiments with total RNA samples
puriﬁed from HeLa cells as prey (11). Figure 2B shows
that amino acid residues 23–33 are required for efﬁcient
rRNA binding by hAPE1, as also conﬁrmed by competi-
tion experiments with the speciﬁc 1–9, 23–33 and
1–33 peptides (Figure 2C). Acetylation of K6 and
K7 residues, which regulates hAPE1 binding to nCaRE
sequences (8), does not inﬂuence the hAPE1 RNA-binding
activity, as determined by competition experiments with
the acetylated peptide, i.e. 1-9ac hAPE1 (Figure 2C). The
reported experiments, relative to hAPE1 binding to 28S
rRNA, were also performed with 18S rRNA giving similar
results (not shown).
Overall, these experiments demonstrate a leading role
for the 23–33 basic amino acid sequence in mediating
hAPE1 binding to RNA.
Speciﬁc lysine residues are required for hAPE1 binding
to RNA
Since electrostatics may drive the RNA-binding activity of
hAPE1, we tested the hypothesis that basic residues within
the 23–33 hAPE1 sequence are responsible for mediating
stable binding to RNA. Thus, we generated mutants of the
protein bearing a triple (K24/K25/K27) and quintuple
(K24/K25/K27/K31/K32) K to A substitutions, here
referred to as hAPE1K3 and hAPE1K5, respectively.
Recombinant proteins were expressed in E. coli and
chromatographycally puriﬁed. SDS–PAGE analyses of
puriﬁed proteins showed that each mutant displays an
altered mobility (Figure 3A, left), possibly due to alter-
ation of its overall charge since LC–MS analyses con-
ﬁrmed the correctness of their masses and the difference
in their apparent mobility observed in SDS–PAGE was
abolished when separating proteins in urea-containing
denaturing gels (not shown). Then, their binding activity
to 34FRNA was measured through EMSA analysis
(Figure 3A, right). The obtained results clearly demon-
strate that the hAPE1 binding to this small RNA strictly
depends on the presence of these lysine residues. GST pull-
down experiments with 28S and 18S rRNA (Figure 3B
and data not shown) were in good agreement with the
EMSA experiments. As expected, hAPE1K5 mutant was
as deﬁcient in binding to both 28S (Figure 3B) and 18S
rRNA (not shown) as the hAPE1N33 deletion mutant.
On the contrary, the hAPE1K3, which was proﬁcient in
binding to 28S RNA, as shown in Figure 3B, showed only
a slightly reduced ability to bind 18S RNA compared to
the entire hAPE1 (not shown).
A
B
Figure 1. RNA-binding activity of 33N-term hAPE1. (A) Primary structure and biophysical parameters of 33N-term hAPE1. (B, left) 33N-term
hAPE1 shows RNA-binding ability. EMSA experiments were performed as described in ‘Materials and Methods’ section with puriﬁed recombinant
hAPE1 or a synthetic 1–33 hAPE1 peptide (33N-term hAPE1). Competition experiments were performed with the indicated amount of peptide
co-incubated with the hAPE1 during the binding reaction. Mixtures were separated on a native 10% (w/v) polyacrylamide gels at 120V for 2h.
F indicates the free 34FRNA oligonucleotide
32P-labelled probe. The image is from a representative gel out of three independent experiments,
(B, right) 33N-term hAPE1 competes with hAPE1 for 28S rRNA binding. GST pull-down experiments were performed with total RNA extracted
from HeLa cells as prey, a 10-fold molar excess of the 33N-term hAPE1 synthetic peptide as competitor and GST, GST–hAPE1 or
GST-hAPE1N33 as baits (see ‘Materials and Methods’ section for details). Histograms represent average values with SDs of three independent
experiments.
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the hAPE1 endonuclease activity on abasic DNA
We (11) and others (25) previously reported that the en-
zymatic activity on abasic dsDNA (34FDNA) of the
hAPE1N33 protein was signiﬁcantly higher than that
of the wild-type protein. We therefore evaluated the
effect of the K to A mutations on the endonuclease
activity of APE1 over abasic dsDNA, by measuring the
kinetic parameters (KM and kCAT) of hAPE1,
hAPE1N33 and the two K to A mutants (Table 1).
A
B
C
Figure 2. Mapping of the RNA-binding domain of hAPE1. (A) Schematic representation of the hAPE1 deletion mutants used. (B–D) An amount of
120pmol of each bait protein was incubated with 10mg of total RNA puriﬁed from HeLa cells, as described in ‘Materials and Methods’ section.
(B, right) After GST pull-down, samples underwent either western blot analysis using an anti-GST antibody or RNA extraction and quantiﬁcation
by reverse transcription and Q-PCR analysis using 28S rRNA speciﬁc primers. The amounts of 28S rRNA recovered were then normalized versus the
amount of bait proteins and the resulting values are plotted in the histograms in which average values with SDs of three independent experiments are
plotted (*P<0.05) (B, left). (C) The same procedure as in (B) was used in the presence of 10-fold molar excess competitor peptides: N1-9 hAPE1
spanning the ﬁrst 9N-terminal aminoacids of APE1; 1–9ac hAPE1 indicates the same peptide bearing acetylation on residues 6 and 7; N23–33 hAPE1
spanning the region 23–33 of hAPE1, and 33N-term hAPE1 spanning the ﬁrst 33N-terminal amino acids of the protein. Histograms represent the
normalized amount of recovered 28S rRNA and the bars represent SDs of three independent experiments (*P<0.05).
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endonuclease activities, an initial set of experiments
(Figure 4A) was performed in order to select the most
suitable enzyme concentration for further analysis. An
enzyme concentration capable of cleaving  7nM
34FDNA over the time of reaction, indicated by the red
spots, was selected for time-lapse experiments and its
value is indicated in the plots. KM and kCAT values for
each enzyme are shown in Table 1, and are in good agree-
ment with the parameters reported earlier by other
authors (25,43).
Our ﬁndings (Table 1) show that the KM value is similar
for all protein variants, therefore suggesting that the
enzyme afﬁnity for the abasic site in the 34FDNA
substrate is not signiﬁcantly affected by the removal of
the 33N-term or by mutation of the critical lysine
residues within the region 23–33. On the contrary, kCAT
values are very different, indicating that the enzymatic
catalysis is faster for the N33 or the K5 mutants than
for the full-length protein. These experiments were per-
formed with different preparations of recombinant
proteins conﬁrming the reliability of our data.
These ﬁndings suggest that molecular interactions
and electrostatics involving the amino acid region 23–33
of hAPE1, though not appreciably changing the
binding afﬁnity to a double-stranded abasic substrate,
participate in the modulation of hAPE1 endonuclease
activity.
a
a
A
B
Figure 3. Lysine residues in the 23–33 basic region are responsible for hAPE1 binding to RNA. (A, left) Lysine to alanine mutants of hAPE1 were
generated through site-directed mutagenesis. Recombinant proteins were expressed in E. coli, puriﬁed to homogeneity and used for further assays.
The correct molecular mass of each recombinant protein was assessed by LC–MS analysis. Representative Coomassie-stained 10% SDS–PAGE of
1mg of each recombinant protein is shown. (A, right) Puriﬁed hAPE1, hAPE1-K3 and hAPE1-K5 proteins were assayed for their ability to bind to
34FRNA by EMSA. A representative EMSA gel image of three independent experiments is shown. (B) GST pull-down experiments were performed,
as described in ‘Materials and Methods’ section, with total RNA extracted from HeLa cells as prey to test the RNA-binding ability of the hAPE1-K3
and hAPE1-K5 mutant proteins in comparison with the wild-type hAPE1 and the hAPE1N33. After pull-down, samples underwent either western
blot analysis (using an anti-GST antibody) to conﬁrm the amount of bait protein present in each sample, or 28S rRNA quantiﬁcation. The amounts
of 28S rRNA recovered after pull-downs were then normalized versus the amount of bait proteins. The resulting histogram shows the average values
with SD of three independent experiments (*P<0.05).
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Figure 4. Lysine residues in the 23–33 basic region control the catalytic activity of hAPE1. (A) For each different hAPE1 proteins, dose-response
experiments were performed in order to evaluate the most suitable concentration of enzyme to be used for the calculation of catalytic constants. An
enzyme concentration capable of cleaving  7nM 34FDNA over the time of reaction, indicated by the red spots, was selected for time-lapse
experiments. (B) Effect of K
+ concentration on the endonuclease activities of hAPE1 and of its mutants, on abasic DNA. Reaction rates,
obtained as in (A), were quantitatively evaluated and the calculated values are plotted. The resulting histogram shows the average values with
SD of three independent experiments performed with different batches of puriﬁed proteins.
Table 1. Kinetic parameters for endonuclease activity on the abasic DNA of hAPE1 and APE1 mutant proteins
hAPE1 hAPE1 K3 hAPE1 K5 hAPE1 N33
KM (nM) 40.57±11.62 31.48±8.19 27.72±5.67 39.29±9.20
kCAT (min
 1) 5.99±0.70 20.22±2.34 67.29±5.61 57.97±8.98
kCAT/KM (nM
 1min
 1) 0.15 0.64 2.62 1.48
Kinetic parameters (KM and kCAT) were calculated from the measurement of the endonucleolytic reaction rates for hAPE1 and the
different mutant hAPE1 proteins using a Cy5-labelled 34FDNA as substrate, at 37 C, as described in (11) and detailed in ‘Materials
and Methods’ section, and using a Lineweaver–Burk plot analysis. In order to evaluate KM and kCAT of the different hAPE1 forms, we
performed time-lapse experiments using increasing concentrations of the substrate. The reactions were monitored at 0, 5, 10, 15 and
20min. For each protein, the concentration of the product increased in a linear manner over time by using the selected enzyme
concentration (refer to Figure 4A). Values represent the mean±SD of three independent experiments performed with different batches
of puriﬁed proteins.
8246 Nucleic Acids Research, 2010,Vol.38, No. 22Such a model would predict a differential sensitivity of
the endonuclease activity of the enzyme to ionic strength
variation for the different hAPE1 mutants here
investigated. We therefore studied the effect of K
+ con-
centration on the catalytic activity of hAPE1 and of its
mutants at concentrations of each enzyme capable of
cleaving the same amount of 34FDNA (as performed
for the experiments reported in Table 1). Data reported
in Figure 4B clearly show that, as expected from previous
results (43), the hAPE1 endonuclease activity was at least
4-fold higher in 150mM KCl than in 40mM KCl.
Consistently with the proposed model, the catalytic
activities of both K5 and N33 protein mutants were es-
sentially not affected by the increase in K
+concentration.
As expected, the K3 mutant showed an intermediate be-
haviour. Accordingly, further enzymatic assays, per-
formed as a function of salt concentration and at the
same protein concentrations, show that while hAPE1
displays a maximum activity at 150mM KCl,
hAPE1N33 is more active at 80mM KCl as the K5
mutant is (Supplementary Figure S3).
Altogether, these data support a model in which
the electrostatic charges of lysine residues in the region
23–33 are involved in the modulation of hAPE1 catalytic
activity, disclosing new unsuspected details in its function-
al regulation. They also suggest that molecular inter-
actions, or even PTMs, involving that region, act as
strong modulators of hAPE1 endonuclease activity.
Characterization of hAPE1/NPM1 binding and mapping
of the amino acids involved in the interaction
We reported earlier that hAPE1 interacts in vivo with
NPM1 and that this interaction determines the localiza-
tion of hAPE1 in nucleoli (11). To evaluate the dissoci-
ation constant (KD) of complexes formed between these
proteins and their variants, SPR experiments were per-
formed. The overlay of relative sensorgrams is reported
in Figure 5A, left. The value of KD of the hAPE1/
NPM1 complex was estimated by plotting RUmax
values, from each SPR-binding experiment, as a function
of NPM1 concentration (Figure 5A, middle). Data ﬁtting
using a non-linear regression analysis provided a KD value
of 3.5±0.3mM. Experiments performed under the same
conditions on the immobilized hAPE1N33 gave a poor
signal variation (the overlay of the sensorgrams is
reported in Figure 5A, right). The degree of mean
RUmax and the lack of dose-response dependence con-
ﬁrmed the absence of a stable binding between
hAPE1N33 and NPM1, as reported earlier (11).
In line with previous ﬁndings, SPR experiments also
indicated that the N-terminal domain of NPM1
(residues 1–117) is responsible for the binding to hAPE1.
In this case, the calculated KD value was 0.668±0.005mM
(Supplementary Figure S4). Collectively, these data
provided support to the hypothesis that the NPM1–
hAPE1 interaction is physiologically relevant and that
the 1–33 region of hAPE1 is responsible for it (11).
Then, we mapped the hAPE1 amino acids involved in
NPM1 interaction through GST pull-down experiments
using the hAPE1N9, hAPE1N22 and hAPE1N33
deletion mutants. Similarly to what was observed for
RNA binding, hAPE1 amino acids within region 23–33
is critical for the interaction with NPM1 (Figure 5B).
Notably, removal of the ﬁrst 22 amino acids, including
the acidic stretch 10–22, increased over 2-fold the
hAPE1 afﬁnity to NPM1, thus suggesting that electrostat-
ics plays a role in the interaction between the two proteins.
GST pull-down experiments performed with the K to A
mutants pointed out that, similarly to what seen for RNA
binding, the presence of K31 and K32, in addition to K24,
K25 and K27, is required for stable binding of hAPE1 to
NPM1 (Figure 5C).
To conﬁrm our in vitro experiments in an in vivo trans-
fection assay, the two hAPE1K3 and hAPE1K5 mutants
were expressed as Flag-tagged proteins in HeLa cells.
hAPE1N33 was used as a control. Notably, the two
mutant proteins (i.e. K3 and K5), particularly the K5,
resulted expressed at a slightly lower levels than the
wild-type, suggesting that this mutation may alter
protein stability. The hAPE1K5 mutant showed a behav-
iour similar to that of hAPE1N33 (11), with a predom-
inant cytoplasmic localization and no colocalization with
NPM1 (Figure 5D, left). The hAPE1K3 mutant, on the
contrary, showed an intermediate phenotype (Figure 5D,
left). Co-immunoprecipitation analysis (Figure 5D, right)
of transiently transfected HeLa cells conﬁrmed the
co-immunoﬂuorescence data showing no interaction
between hAPE1K5 and NPM1 as that of hAPE1N33.
We can therefore infer that the NLS sequence is not suf-
ﬁcient to guarantee for a complete nuclear localization of
hAPE1 in the absence of charged residues at position K24,
K25, K27, K31 and K32, thus suggesting that the RNA-
and/or the NPM1-binding abilities may play a signiﬁcant
role in hAPE1 nuclear maintenance, as hypothesized
earlier (11).
Taken together, these data provide the molecular basis
for explaining the inhibitory effect of NPM1 on hAPE1
RNA binding observed previously (11). To better substan-
tiate this, we performed competition experiments with
NPM1 and hAPE1 in RNA-binding assays by GST pull-
down analysis. Figure 5E shows that hAPE1 directly binds
rRNA molecules, but the addition of soluble recombinant
NPM1 in a 50% molar excess to the GST–hAPE1 bait
inhibits hAPE1 binding to rRNA. This effect seems due
to protein–protein interaction between hAPE1 and
NPM1, since the rRNA-binding activity of GST-NPM1
for the 28S rRNA was lower than that of GST–hAPE1
alone. These data again support the notion that protein–
protein interactions account for the inhibitory effect of
NPM1 over hAPE1 binding to RNA, as suggested
earlier (11).
As NPM1 stimulates hAPE1 endonuclease activity on
34FDNA substrates (11), we investigated whether these
critical lysine residues may play a role in enzyme activa-
tion. Endonuclease assays under standard conditions at
40mM KCl, either with or without NPM1, showed that
this protein stimulates only the activity of the wild-type
hAPE1 (Figure 5F) in a way similar to that described
earlier (11). We then checked whether this stimulatory
effect could be observed at higher K
+ concentration
(150mM KCl), where binding of hAPE1 to NPM1 still
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Figure 5. Mapping of the amino acids involved in hAPE1 binding to NPM1. (A, left) Overlay of SPR sensorgrams relative to the binding of NPM1
to immobilized hAPE1 (see ‘Materials and Methods’ section for experimental details). (A, middle) Plot of RUmax from each binding versus NPM1
concentrations (micro molar); data were ﬁtted by non-linear regression analysis. (A, right) Overlay of SPR sensorgrams relative to the same
experiment carried out on immobilized hAPE1N33. (B and C) GST pull-down experiments with different hAPE1 deletion (B) or with K to A
(C) mutants as baits and a recombinant NPM1 as prey. Pull-down samples underwent western blot analysis using either an anti-GST antibody or an
anti-NPM1 antibody. The NPM1 to GST signal intensity ratio for each sample is plotted in the histogram. (D) K24, K25, K27, K31 and K32
residues of hAPE1 are necessary for protein nucleolar localization and binding to NPM1. HeLa cells were transfected with pcDNA5.1 expression
vector containing the cDNA of Flag-tagged hAPE1 or that of hAPE1N33, hAPE1K3 or hAPE1K5 mutants. Confocal microscopy (left) of HeLa
cells ﬁxed and stained with antibodies against NPM1 (red) and ectopic Flag-tagged hAPE1 (green). Total cell extracts from transiently transfected
HeLa cells with empty vector, hAPE1, hAPE1N33, hAPE1K3 or hAPE1K5 mutants were co-immunoprecipitated. Co-immunoprecipitated material
was separated onto 10% SDS–PAGE and analysed by western blotting to evaluate the levels of NPM1 binding by using the speciﬁc antibody. (E)
hAPE1 binding to 28S rRNA is inhibited by NPM1. GST pull-down experiments with puriﬁed hAPE1 were carried out using 100pmol of each bait
protein incubated with the indicated amount of total RNA from HeLa cells. Pull-down samples were analysed as described in Figure 2B, The
amounts of 28S rRNA recovered after pull-downs were then normalized versus the amount of bait proteins. The resulting histogram shows the
average values with SD of three independent experiments. (F) Effect of K
+ concentration on the stimulation of the endonuclease activities of hAPE1
and its mutants induced by NPM1. For each recombinant hAPE1 protein, 20pM of each enzyme were incubated with or without 0.4nM NPM1 and
reacted, in either 40 or 150mM KCl, with the 34FDNA as described in ‘Materials and Methods’ section. Then, reaction mixtures were separated in
denaturing gels, which were then scanned for quantiﬁcation. Histograms, representing the fold of increase in the reaction rates of each hAPE1
recombinant proteins, are the mean of two independent experiments.
8248 Nucleic Acids Research, 2010,Vol.38, No. 22occurs (11). As expected, no effect was observed for any of
the enzymes tested. Thus, these results support the hy-
pothesis that the hAPE1 region 23–33, through electro-
statics, behaves as a site of allosteric regulation of the
enzyme endonuclease activity.
hAPE1 in vivo acetylation at K27, K31, K32 and K35
K to A mutation mimicks constitutive acetylation in vivo.
To probe whether the critical lysines we studied in the
present work are acetylated in vivo, Flag-tagged hAPE1
from stably expressing HeLa cells (11) was
immunopuriﬁed, excised from SDS–PAGE, S-alkylated,
digested with endoprotease AspN, and subjected to
massive nanoLC–ESI–LIT–MS/MS and MALDI–TOF–
MS experiments. The protease was chosen to generate
peptides having suitable dimension/properties for
optimal PTMs mapping analysis of the 15–35 amino
acid region.
In addition to a number of non-modiﬁed peptides,
nanoLC–ESI–LIT–MS/MS analysis revealed the occur-
rence of speciﬁc acetylated species bearing a variable
modiﬁcation extent. In particular, peptides (15–33)Ac,
(15–33)Ac2, (15–33)Ac3, (15–35)Ac, (15–35)Ac3 and
(15–35)Ac4 at m/z 2186.4, 2228.3, 2270.4, 2429.1, 2513.3
and 2555.5 (theoretical value: 2186.2, 2228.2, 2270.2,
2429.3, 2513.3 and 2555.3), respectively, were detected in
the total ion current MS trace proﬁle of the hAPE1 digest.
D
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Figure 5. Continued.
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peptide counterparts were also observed (data not
shown). Conﬁrmation of the peptide assignment and
direct localization of the acetylation sites was obtained
from MS/MS data. As representative examples, the frag-
mentation spectra of peptides (15–33)Ac3 and (15–35)Ac4
are presented in Figure 6. Accordingly, nanoLC–ESI–
LIT–MS/MS experiments demonstrated that hAPE1 is
acetylated at K27, K31, K32 and K35. Based on the
data from MALDI–TOF–MS analysis that, combined to
nanoLC–ESI–LIT–MS/MS, allowed coverage of 68% of
the protein sequence, no additional PTMs were observed
within this peptide region. Furthermore, the reliability of
our approach was substantiated by the analysis of the
hAPE1 tryptic digest, which conﬁrmed acetylation
occurring at K6 and K7 (data not shown), as
demonstrated earlier (8).
Evolutionary analysis of APE1N-terminal sequence
While being highly conserved in mammals, the APE1
33N-term is poorly conserved in other organisms
including some vertebrates (5,17). We sought divergences
in APE1 33N-terms within vertebrates in order to correl-
ate them with protein binding to RNA and endonuclease
activities. An evolutionary tree depicting the relationship
between the vertebrate sequences is shown in Figure 7A.
The sequences from amphibians and ﬁshes represent a
separate branch from mammalian ones. As reported
earlier for the Cys content analysis, it turned out that,
based on the N-terminal portion of the protein, zebraﬁsh
APE1 (zAPE1) is evolutionarily the most distant sequence
from hAPE1 within vertebrate sequences (17). Alignment
analysis (Figure 7B) suggests that during phylogenesis, the
ﬁrst three lysine residues (i.e. K24, K25 and K27) were
conserved, while the other two (i.e. K31 and K32),
occurring in mammals and Xenopus, might come from
an insertion. Thus, ﬁshes’ APE1, which lacks these lysine
residues, should act as a loss-of-function protein with
regard to its RNA-binding. To test this hypothesis,
we analysed the RNA-binding activity of zAPE1 in
comparison with that of hAPE1. EMSA (Figure 7C,
left), performed with puriﬁed recombinant proteins
(Supplementary Figure S5), clearly demonstrated that
zAPE1 binds to RNA at a signiﬁcantly lower extent
than hAPE1. We consequently evaluated the endonuclease
activity of zAPE1 on abasic dsDNA in comparison to that
of hAPE1 and of the different K to A mutants in a set of
dose-response experiments. As it is evident in Figure 7C,
right, zAPE1 endonuclease activity was higher than that
of hAPE1 and similar to that of the K to A and of the
N33 deletion mutants. Therefore, both the RNA-
binding and the endonuclease activities of zAPE1 are dif-
ferent from that of hAPE1 and resemble those of the
mutants we tested, strongly supporting the evolutionary-
based hypothesis that the K31 and K32 evolutive insertion
may represent a phylogenetic acquisition of a further point
for functional regulation of the protein through PTMs.
Domain swapping experiments are actually in progress
to further substantiate this hypothesis.
DISCUSSION
Although some data suggest that hAPE1N-terminal
region is important for recruiting proteins involved in
BER processes (20) or in RNA metabolism (11), current
opinion conﬁnes its value to the presence of the NLS
sequence and of a pair of lysine residues (K6 and K7)
whose acetylation controls the expression of some genes
(8,32). Based on the experimental evidences that: (i) the
truncated form of hAPE1 and its K to A mutants in the
N-terminal domain, have higher endonuclease activity
than the wild-type protein on abasic dsDNA (this
study); (ii) hAPE1N33 does not cleave 34FRNA (11);
(iii) hAPE1N33, as well as hAPE1 K5 mutant shows a
signiﬁcantly reduced ability to bind RNA molecules and
NPM1 with respect to hAPE1 [(11) and this study]; (iv) the
behaviour of K3 mutant on both binding to RNA and
NPM1 and endonucleolytic activity is intermediate
between that of the wild type and that of hAPE1N33
(this study), we propose that the hAPE1 ﬁrst 33 amino
acids might have an important role in regulating its
activities and the regulatory function of the K residues
within the region 23–33 may require differential and
non-mutually exclusive modulation.
hAPE1 full-length is endowed with distinct domains
capable of binding oligonucleotides through electrostatic
interactions (15). In addition to the positively charged
residues within the catalytic domain that drive the
binding of abasic nucleotides to the active site, the recog-
nition of substrates and/or reaction product also involves
residues within the 33N-term. Although positively charged
residues are abundant in the 33N-term—eight lysines and
two arginines conferring to the whole protein a net
positive charge—results presented in this study clearly
indicate that among them, a speciﬁc subset of lysine
residues, located in the portion 23–33, plays an active
role in hAPE1 catalysis.
The experimental data reported here on the role of the
33N-term in hAPE1 catalysis may be tentatively inter-
preted in structural terms by assuming that the binding
of apurinic/apyrimidinic dsDNA is essentially driven by
the residues of the catalytic site. On the other hand, the
reduced afﬁnity of the hAPE1 catalytic site for other DNA
structures, such as reaction product or single stranded
RNA/DNA molecules, makes the role of the 33N-term
relevant. Its involvement in oligonucleotide recognition
is not surprising, as Gly41 is not far (<8A) from a
15-bp DNA duplex containing an abasic site
(Supplementary Figure S6), when this nucleotide is com-
plexed with a truncated (N40) form of APE1 (15).
Within this framework, the decreased catalytic activity
of hAPE1 on dsDNA compared to that exhibited by
hAPE1N33 should be ascribed to the contribution of
the 33N-term to the electrostatic binding of the reaction
product, being consistent with the increased activity
shown by hAPE1K5 and with the effect of KCl concen-
tration on the hAPE1 activity and not on that of the
mutants hAPE1K5 and hAPE1N33. The hypothesis is
supported by other studies, which show that the catalytic
activity of hAPE1 on abasic RNA/ssDNA (where the sub-
strate binding is markedly dependent on the presence of
8250 Nucleic Acids Research, 2010,Vol.38, No. 22Figure 6. Lysine residues in the 23–33 basic region are acetylated in vivo.( A) Tandem mass spectrometry of some acetylated peptides present in the
endoprotease AspN digest of hAPE1 puriﬁed from HeLa cells (see ‘Materials and Methods’ section for details). The fragmentation mass spectrum of
the quadruply charged ion at m/z 568.5 associated with the peptide (15–33)Ac3 is shown. (B) The fragmentation mass spectrum of the triply charged
ion at m/z 852.5 associated with the peptide (15–35)Ac4 in shown. Spectral assignment demonstrated that hAPE1 is acetylated at K27, K31, K32 and
K35, as highlighted in the peptide sequence associated to each panel.
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Figure 7. Evolutionary analysis of APE1N-terminal sequence. (A) Evolutionary tree for vertebrate APE1 sequences based on the analysis of amino
acid sequences aligned with the ﬁrst 60 amino acids in hAPE1. Numbers indicate the bootstrap values obtained during the construction of the tree.
Mammalian and non-mammalian vertebrate APE1 sequences are found in distinct branches with C. elegans representing the sequence most evolu-
tionarily distant from the human one. HUMAN, H. sapiens; PANTRO, P. troglodytes; MACACA, M. mulatta; HORSE, E. caballus; PIG, S. scrofa;
COW, B. taurus; DOG, C. lupus familiaris; ORNITHO, O. anatinus; CELEGANS, C. elegans; URCHIN, S. purpuratus; MOUSE, M. musculus;
RAT, R. norvegicus; XENLAE, X. laevis; XENTRO, X. tropicalis; SALMON, S. salar; ZEBRAFISH, D. rerio; STICKLEBACK, G. aculeatus.( B)
Multiple sequence alignment of N-term APE1 sequences. Multiple alignment was performed using the software MAFFT (v6.531b) (35), available at
the EMBL-EBI server (www.ebi.ac.uk/Tools/sequence.html). Arrows indicate K24, K25, K27, K31 and K32, respectively. (C, left) zAPE1 has lower
afﬁnity for RNA than hAPE1, as determined by EMSA. Reactions were performed as described in ‘Materials and Methods’ section with homo-
geneously puriﬁed recombinant proteins. The mixtures were separated on a native (non-denaturing) 8% (w/v) polyacrylamide gel at 120V for 2h. In
each reaction, 2.5pmol of ssFRNA were used. F indicates the free 34FRNA oligonucleotide
32P-labelled probe. A representative EMSA gel image of
three independent experiments, using the abasic ssFRNA sequence, is shown. (C, right) zAPE1 is catalytically more active than hAPE1 over abasic
DNA. AP endonuclease activity of different mutant APE1 enzymes was tested by performing a dose-response experiment, as described in the
‘Materials and Methods’ section.
8252 Nucleic Acids Research, 2010,Vol.38, No. 22the 33N-term) is strongly reduced >50mM KCl, whereas
that on dsDNA is high even at 200mM (43–45).
Substrate recognition, cleavage and product release are
separable molecular steps. The stimulation of DNA Pol b
over hAPE1 activity, through elimination of the incision
product, strongly suggests that release of the catalysis
product is the limiting step in the removal of AP-sites by
hAPE1 (15,46). Interestingly, Marenstein et al. (47)
showed no product inhibition effect on the rate of hy-
drolysis of abasic ssDNA, while such an inhibition was
observed for the corresponding dsDNA, thus suggesting
that dsDNA product can make the difference in being
more strongly bound to the N-terminal disordered arm.
Altogether, our results point to the fact that acetylation of
the critical lysine residues located in the 23–33 protein
sequence and involved in inhibition of both NPM1 and
RNA interaction, is also very important in modulating
hAPE1 endonuclease activity, presumably by preventing
the enzyme N-terminal region to assume an
electrostatically stabilized conformation associated to a
reduced endonuclease activity. Therefore, we can specu-
late that the N-terminal tail of hAPE1 may regulate the
overall enzyme catalytic turnover, reducing the rate of
product release without appreciably affecting the AP-site
recognition speciﬁcity of the enzyme. The possibility that
the product release step may be regulated in vivo by PTMs
or interactions with other proteins, such as NPM1 (11),
CSB (21) or XRCC1 (20), could be viewed in the light of
the necessity to coordinate the BER activities on different
substrates in order to protect the abasic DNA repair inter-
mediate and to ensure its coordinated processing.
Notably, some of the lysine residues (i.e. K27, K31 and
K32) involved in the interaction with NPM1 and with
RNA and responsible for modulating the catalytic
activity of the enzyme, were found acetylated in vivo
(Figure 6), thus providing further biological relevance to
our ﬁndings. Based on the evidence that mutations
inserted to mimic constitutive acetylation (the K to A
mutants) progressively increase the catalytic activity of
hAPE1 on abasic dsDNA, the occurrence of such
speciﬁc PTMs may well explain the observation made by
different laboratories that immunopuriﬁed hAPE1 forms
from mammalian cells retains signiﬁcantly higher enzym-
atic activity than that of recombinant proteins expressed
in E. coli. From our data we can also infer that simultan-
eous multiple acetylation is required to modulate the dif-
ferent hAPE1 known activities.
Taken together and in light of previous works
(11,27,48), our current data allow to propose the molecu-
lar model of APE1 functions reported in Figure 8. After
APE1 scans nucleic acids in search of its substrate and
catalyzes the cleavage of the abasic site, acetylation of
the critical lysine residues (i.e. K27, K31 and K32)
should stimulate the overall hAPE1 endonuclease
activity through increasing the product release rate.
Speciﬁc acetylation may also modulate the interaction of
hAPE1 with NPM1 (and possibly with other unidentiﬁed
protein partners) and thus could redirect a functionally
active form of hAPE1 from buffering storage sites, such
as nucleoli, toward the active sites of DNA repair.
Moreover, acetylation of the critical lysine residues may
also inhibit hAPE1 action in RNA metabolism by pre-
venting its RNA-binding activity. Notably, a recent
paper provided the ﬁrst evidence for ubiquitination
occurring on K24, K25 and K27 (31). Interestingly, an
ubiquitin-fused hAPE1 recombinant protein, in which
the ubiquitin sequence is sandwiched between A23 and
K24 (mimicking constitutively ubiquitinated hAPE1)
was clearly excluded from nuclei (31). Thus, it can be
speculated that post-translational modiﬁcations occurring
on or near these critical lysine residues may play a signiﬁ-
cant role in controlling hAPE1 subcellular distribution, its
functional activation and thus its biological function in
mammalian cells.
From an evolutionary perspective, hAPE1 activity was
made tunable (through post-translational modiﬁcations or
the interaction with other proteins) or expanded toward
other substrates with the acquisition of a positively
charged N-terminus, without major modiﬁcations of its
catalytic site, which retained the ‘canonical’ function
towards abasic dsDNA. The existence of such an
N-terminal extension for mammals only (Figure 7), may
suggest its evolutionary signiﬁcance in facing increased
functional complexity. The intrinsic lack of structure of
this domain can confer functional advantages to hAPE1,
including the ability to bind to several different targets (i.e.
NPM1, XRCC1, CSB, RNA, etc.), thus allowing precise
control over the thermodynamics of the binding process
(49). Since the 33N-term is required for both stabilizing
the interaction to RNA and controlling the overall hAPE1
enzymatic activity through decreasing the rate of product
release, this double role provides a ‘relay’ for molecular
regulation with extremely useful biological signiﬁcance
and could also be envisioned in the light of preventing
formation of harmful unprotected DNA strand breaks.
Interestingly, through multiple interactions with different
protein partners, the enzymatic activity of hAPE1 could
be ﬁnely tuned, in association with the biological circum-
stances, in a time-dependent manner. While this work was
in progress, a article by Yu et al. demonstrated that the K
residues within the 24–35 region, which have a differential
protection pattern between free and DNA-bound
complexes of APE1, are involved in a conformational
change concomitant with DNA binding and catalysis
and with interaction with Pol b (50). This work and our
current data strongly support the notion that these critical
residues may indeed constitute a structural switch for
hAPE1 functional regulation.
Regulation of the interaction of hAPE1 with NPM1
(11) may have profound biological consequences during
cell response to stressor signals. NPM1 physically inter-
acts with p53 and is believed to regulate this tumor sup-
pressor protein (51). p53-signaling network, and its
involvement of ubiquitin in particular, plays an important
role in APE1 functional regulation, as recently
demonstrated (31). During DNA damage stress
response, ARF dissociates from NPM1 within nucleoli
and relocalizes to the nucleoplasm where it sequesters
the p53-ubiquitinating enzyme MDM2, thus leading to
p53 up-regulation and functional activation (52). These
data support the hypothesis that nucleolus may represent
a major cellular stress sensor transmitting signals to the
Nucleic Acids Research, 2010,Vol.38, No. 22 8253system for regulation of p53 activity (53). Thus, a careful
elucidation of the p53-signalling networks and their in-
volvement in the DNA repair pathway coordinated by
hAPE1 is an important subject for molecular carcinogen-
esis and deserves further study. To this aim, work is now
in progress in our laboratory to study the modulation of
the hAPE1 interactome network during genotoxic damage
and to evaluate its impact on the dynamics of nucleolar
hAPE1 distribution. In conclusion, our work underscores
the functional importance of the neglected unstructured
hAPE1N-terminal domain and points to the need of struc-
tural details on this protein region for understanding the
ﬁne-tuning mechanisms regulating this multi-functional
protein.
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Figure 8. Proposed mechanism of regulation of hAPE1 functions and compartmentalization through acetylation of critic lysine residues. Within
cells, APE1 is present with different degrees of acetylation on residues 27, 31, 32, 35 (Ac-APE1) and may also be involved in interaction with NPM1
and/or different protein partners (indicated here as ‘X’ and ‘Y’). Genotoxic stress may shift the equilibrium between the non-acetylated and the
Ac-APE1 forms toward these latter and more active form, possibly by its reduced afﬁnity for the incised DNA product. Acetylation, in turn, may
inhibit binding to RNA substrates thus, possibly, this PTM may change the equilibrium of the hAPE1 pool from the RNA-bound to the
DNA-bound substrates. Moreover, acetylation may also control compartmentalization of hAPE1 within speciﬁc subnuclear structures (such as
nucleoli), where the enzyme could be stored once bound to interacting partners as NPM1. Whether NPM1 may speciﬁcally participate in DNA
repair inside of nucleoli, or even outside of the subnuclear condensed area, is currently unknown. In the ﬁrst case, the genome containing rRNA gene
may be a favoured substrate for hAPE1 in vivo. On the other hand, if the latter is the case, stimuli triggering NPM1 to get out of nucleoli may affect
the cell response in terms of hAPE1 impact on genome stability. Further experiments are currently underway to address these issues.
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